PE117199A1 - Formulaciones parasiticidas - Google Patents
Formulaciones parasiticidasInfo
- Publication number
- PE117199A1 PE117199A1 PE1998000903A PE00090398A PE117199A1 PE 117199 A1 PE117199 A1 PE 117199A1 PE 1998000903 A PE1998000903 A PE 1998000903A PE 00090398 A PE00090398 A PE 00090398A PE 117199 A1 PE117199 A1 PE 117199A1
- Authority
- PE
- Peru
- Prior art keywords
- implant
- parasiticide
- parasiticide formulations
- formulations
- milbemycin
- Prior art date
Links
- 230000000590 parasiticidal effect Effects 0.000 title abstract 2
- 239000002297 parasiticide Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000007943 implant Substances 0.000 abstract 2
- 239000005660 Abamectin Substances 0.000 abstract 1
- 241000283690 Bos taurus Species 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 241001494479 Pecora Species 0.000 abstract 1
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006835 compression Effects 0.000 abstract 1
- 238000007906 compression Methods 0.000 abstract 1
- 210000005069 ears Anatomy 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 abstract 1
- 244000045947 parasite Species 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UN IMPLANTE SOLIDO QUE COMPRENDE: A) AL MENOS UN COMPUESTO PARASITICIDA QUE TIENE UNA BAJA SOLUBILIDAD ACUOSA POR DEBAJO DE 100 �g/ml, Y QUE PUEDE SER AVERMECTINA, MILBEMICINA, ENTRE OTROS; Y B) EXCIPIENTES DE COMPRESION, ENTRE LOS QUE SE INCLUYE UN AGENTE DE RELLENO TAL COMO LACTOSA. EL PRESENTE IMPLANTE TIENE FORMA DE BARRITA Y ESTA ADAPTADO PARA LA IMPLANTACION EN LAS OREJAS DE VACAS U OVEJAS O CUALQUIER ANIMAL QUE LO REQUIERA, DE MANERA QUE LES PROPORCIONE PROTECCION PROLONGADA FRENTE A PARASITOS
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9720228.7A GB9720228D0 (en) | 1997-09-23 | 1997-09-23 | Parasiticidal formulations |
| GBGB9810143.9A GB9810143D0 (en) | 1998-05-12 | 1998-05-12 | Parasiticidal formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE117199A1 true PE117199A1 (es) | 1999-11-20 |
Family
ID=26312302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000903A PE117199A1 (es) | 1997-09-23 | 1998-09-22 | Formulaciones parasiticidas |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1014970A1 (es) |
| JP (1) | JP2001517622A (es) |
| AP (1) | AP9801350A0 (es) |
| AR (1) | AR013509A1 (es) |
| AU (1) | AU9742298A (es) |
| BR (1) | BR9812385A (es) |
| CA (1) | CA2304283A1 (es) |
| GT (1) | GT199800149A (es) |
| MA (1) | MA24655A1 (es) |
| PA (1) | PA8459501A1 (es) |
| PE (1) | PE117199A1 (es) |
| TN (1) | TNSN98175A1 (es) |
| WO (1) | WO1999015166A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPP279698A0 (en) * | 1998-04-03 | 1998-04-30 | Sunscape Developments Limited | Sustained release formulation |
| US6645192B2 (en) | 1998-09-30 | 2003-11-11 | Ivy Animal Health, Inc. | Pellet implant system for immediate and delayed release of antiparasitic drug |
| AU1556000A (en) * | 1999-11-22 | 2001-06-04 | Akzo Nobel N.V. | Composition allowing predefined and controlled release of active ingredient, preparation thereof and use |
| US6953586B1 (en) | 2000-06-08 | 2005-10-11 | Ivy Animal Health, Inc. | Growth promoting pharmaceutical implant |
| DE10032878A1 (de) * | 2000-07-06 | 2002-01-17 | Bayer Ag | Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier |
| AUPR602501A0 (en) * | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release pharmaceutical composition |
| AUPR602401A0 (en) * | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release delivery system |
| AUPR610501A0 (en) * | 2001-07-04 | 2001-07-26 | Smart Drug Systems Inc | Treatment of parasitic disease |
| US7918863B2 (en) | 2005-06-24 | 2011-04-05 | Conceptus, Inc. | Minimally invasive surgical stabilization devices and methods |
| EP3634583A4 (en) * | 2017-06-06 | 2021-03-03 | Merck Sharp & Dohme Corp. | LONG-LASTING EFFECT IMPLANT FOR THE TREATMENT OF INFECTIOUS DISEASES |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0240274A3 (en) * | 1986-04-03 | 1990-03-14 | Merck & Co. Inc. | Avermectins as growth promotant agents |
| US4847243A (en) * | 1987-10-08 | 1989-07-11 | Merck & Co., Inc. | Treatment for fescue toxicosis in grazing animals |
| NZ239370A (en) * | 1990-08-22 | 1994-04-27 | Merck & Co Inc | Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone |
| US5411737A (en) * | 1991-10-15 | 1995-05-02 | Merck & Co., Inc. | Slow release syneresing polymeric drug delivery device |
-
1998
- 1998-09-04 CA CA002304283A patent/CA2304283A1/en not_active Abandoned
- 1998-09-04 JP JP2000512535A patent/JP2001517622A/ja active Pending
- 1998-09-04 AU AU97422/98A patent/AU9742298A/en not_active Abandoned
- 1998-09-04 EP EP98951367A patent/EP1014970A1/en not_active Withdrawn
- 1998-09-04 WO PCT/EP1998/005720 patent/WO1999015166A1/en not_active Ceased
- 1998-09-04 BR BR9812385-8A patent/BR9812385A/pt not_active IP Right Cessation
- 1998-09-17 AP APAP/P/1998/001350A patent/AP9801350A0/en unknown
- 1998-09-17 PA PA19988459501A patent/PA8459501A1/es unknown
- 1998-09-21 AR ARP980104712A patent/AR013509A1/es unknown
- 1998-09-22 MA MA25268A patent/MA24655A1/fr unknown
- 1998-09-22 GT GT199800149A patent/GT199800149A/es unknown
- 1998-09-22 TN TNTNSN98175A patent/TNSN98175A1/fr unknown
- 1998-09-22 PE PE1998000903A patent/PE117199A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2304283A1 (en) | 1999-04-01 |
| PA8459501A1 (es) | 2000-05-24 |
| AU9742298A (en) | 1999-04-12 |
| WO1999015166A1 (en) | 1999-04-01 |
| TNSN98175A1 (fr) | 2005-03-15 |
| GT199800149A (es) | 2000-03-15 |
| BR9812385A (pt) | 2000-09-12 |
| AR013509A1 (es) | 2000-12-27 |
| EP1014970A1 (en) | 2000-07-05 |
| AP9801350A0 (en) | 2000-03-17 |
| JP2001517622A (ja) | 2001-10-09 |
| MA24655A1 (fr) | 1999-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20000939A1 (es) | Formulaciones de fsh y variantes de fsh, productos y metodos | |
| ES2077530B1 (es) | Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales. | |
| AR044433A1 (es) | Composicion repelente contra insectos, metodo para reducir la incidencia de una enfermedad infecciosa provocada por una plaga de objetivo que comprende dicha composicion y sus usos | |
| BR0114799A (pt) | Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos | |
| ES2067696T3 (es) | Composiciones de liberacion sostenida para tratar la enfermedad periodontal. | |
| AR013488A1 (es) | COMPOSICIoN GERMICIDA ACUOSA PARA EL TRATAMIENTO O PREVENCIoN DE ENFERMEDADES INFECCIOSAS DE LAS PEZUNAS DE ANIMALES, Y USO DE DICHA COMPOSICIoN | |
| BR0008405A (pt) | Composição de fator viii formulada sem a adição de albumina, uso de uma composição de fator viii, e, método de liofilizar uma formulação farmacêutica aquosa | |
| ES2139021T3 (es) | Composiciones germicidas de detergente-yodo que tienen un contenido reducido de detergente. | |
| BRPI0412975A (pt) | espuma penetrante para uso farmacêutico | |
| PA8484301A1 (es) | Formulaciones farmaceuticas de liberacion controlada | |
| CR7089A (es) | Formulaciones liquidas para aplicacion dermica para la lucha contra insectos parasitantes en animales | |
| ES2195169T3 (es) | Vacunas contra calmidias y composiciones inmunogenicas que contienen un antigeno de membrana externa y metodos para su preparacion. | |
| ES2146300T3 (es) | Utilizacion de composiciones antihelminticas para el tratamiento de infecciones causadas por anoplocephala perfoliata en equidos. | |
| PE117199A1 (es) | Formulaciones parasiticidas | |
| ES2162319T3 (es) | Uso del agente quelante clioquinol para la fabricacion de una composicion farmaceutica para el tratamiento de la enfermedad de alzheimer. | |
| ES2063033T3 (es) | Empleo de igf-ii en el tratamiento de la enfermedades de los huesos. | |
| ES2094702B1 (es) | Composiciones farmaceuticas para la prevencion y el tratamiento de enfermedades cancerosas y procedimiento para su preparacion. | |
| AR017925A1 (es) | Una formulacion acuosa para verter, topicamente aceptable, adaptada para su aplicacion externa localizada en un animal, su uso y un metodo para formularla | |
| PE3096A1 (es) | Formulacion conteniendo selenio | |
| AR021690A1 (es) | Empleo de inhibidores del canal de ktq1 para la preparacion de un medicamento para el tratamiento de enfermedades, que son provocadas por helmintos yectoparasitos. | |
| ES2036589T5 (es) | Un procedimiento para la preparacion de una composicion veterinaria para uso en el tratamiento o profilaxis de alteraciones mamarias en animales no humanos. | |
| ES2163631T3 (es) | Un peptido mejorado, composicion inmunogenica y vacuna o preparacion medica, un procedimiento para inmunizar a los animales contra la hormona lhrh, analogos del peptido lhrh repetidos en tandem y su uso como vacuna. | |
| PA8459201A1 (es) | Composicion farmaceutica antimastitica a base de extractos de origen natural y procedimiento para fabricarla | |
| ES2185310T3 (es) | Agente antivirico herbario. | |
| MX172107B (es) | Procedimiento para la desinfeccion de masas para vaciado medicinales |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |